In order to find out new compounds having antineoplastic activity, bis-tyrosine diaqua nickel (II) complex was synthesized and characterized. The antineoplastic activity of the compound was judged by measuring inhibition of tumour growth and enhancement of survival time of EAC cell bearing mice. In addition its effects on haematological parameters and serum alkaline phosphatase activity of both normal and EAC bearing mice were also studied. The test compound significantly inhibited the tumour growth and increased life span of tumour bearing mice at dose 10 mg/kg i.p. The treatment also recovered the perturbed haematological parameters as well as the serum alkaline phosphatase activity towards normal. The host toxicity of the test compound was found to be negligible. The compound can be considered as an effective antineoplastic agent.
INTRODUCTION
Researches involving metal complexes have been extensively carried out [1] [2] [3] [4] owing to their potential applications in biological and pharmaceutical fields. Antineoplastic activities of various complexes of platinum, nickel, copper, zinc etc. are well known. 3, 5, 6 Europium(III) complexes with some schiff bases are found to be effective semicarbazone have also been reported recently. 9 The present study has been focused on the utilization of a nickel complex with tyrosine to evaluate its efficiency in cell growth inhibition and enhancement of life span of tumour bearing mice inoculated with ehrlich ascites carcinoma (EAC) cells. The study has been extended to examine also the effect of the compound on some perturbed haematological parameters and alkaline phosphatase activity of tumour bearing mice.
MATERIALS AND METHODS
Chemicals. All chemicals were purchased from BDH (England) and used without further purification.
Animal. Adult Swiss Albino male mice of 6-8 weeks of age weighing 20-25 grams were used throughout the study. Haematological studies. Haematological parameters were studied with the test compound at doses 10 mg/kg i.p and 5 mg/kg i.p both in normal and tumour bearing mice following usual method. Statistical analysis. The student t-test was used for the statistical analysis of the results. P values < 0.001 were considered as significant. 
RESULTS AND DISCUSSIONS
IR (KBr) spectrum of the test compound showed a broad absorption at 3600-3200 cm - (Table 1) are in accordance with the formula shown in the Figure 1 . Haematological parameters of tumour bearing mice on day 12 were found to be significantly altered from those of normal group ( Table 2 ). The total WBC count was found to be increased with a reduction of haemoglobin content of RBC. The total number of RBC showed a significant change. In differential count of WBC, the percentage of neutrophils increased while the lymphocyte count decreased. At the same time interval the Ni(II) complex (10 mg/kg i.p. 10 days) treatment could restore haemoglobin and RBC values to normal. The increased WBC counts and differential counts were also found to be altered towards normal following the Ni(II) complex treatment. Practically no alteration of haematological parameters in the Ni(II) complex (10 mg/kg i.p. 10 days) treated normal mice was observed (Table 2) . Growth of EAC cells in mice showed a depletion of ALP activity in serum. Significant recovery of the enzyme activity was found in the serum of tumour bearing mice following the Ni (II) complex (10 mg/kg i.p., 10 days) treatment (Table 3) . Results presented in this study show that bistyrosinediaqua nickel (II) complex (10 mg/kg i.p., 10 days) inhibits growth of EAC cells significantly in mice and also enhances their life span. The bioassay experiment shows reduction of transplantability of EAC cells treated with the Ni (II) complex indicating loss of viability of the treated cells. Perturbation of haematological parameters in tumour bearing mice is partly responsible for the toxic effects produced in them. In addition myelosuppression in cancer chemotherapy is a common phenomenon that is responsible for poor prognosis.
14 The Ni (II) complex treatment inhibits tumour cell growth, enhances survival of treated mice and restores the haematological parameters. Depletion of alkaline phosphatase activity in tumour bearing mice is also found to be restored by the Ni (II) complex treatment. The observations described above show the efficiency of bis-tyrosinediaqua nickel (II) with the above mentioned dose (10 mg/kg i.p.). The compound has practically no adverse side effect on the host.
CONCLUSION
Based on these informations, it can be concluded that, bis-tyrosinediaqua nickel (II) is an effective antineoplastic agent and can be utilized in combination with other suitable drugs to protect the host haematological parameters.
